Boobalan Pachaiyappan
Stock Analyst at Roth MKM
(0)
# 4231
Out of 5,253 analysts
8
Total ratings
50.00%
Success rate
-6.45%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Verona Pharma | Initiates Coverage On: Buy | 68 | 53.96 | 26.02% | 1 | Jan 10, 2025 | |
Reviva Pharmaceutica... | Initiates Coverage On: Buy | 7 | 1.74 | 302.3% | 1 | Jan 10, 2025 | |
Cingulate | Initiates Coverage On: Buy | 12 | 4.79 | 150.52% | 1 | Jan 10, 2025 | |
Gain Therapeutics | Maintains: Buy | 7 7 | 2.12 | 230.19% | 2 | Dec 24, 2024 | |
CervoMed | Initiates Coverage On: Buy | 45 | 2.26 | 1891.15% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 13.1 | 121.37% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.59 | 528.93% | 1 | Dec 5, 2024 |